Subscribe
shutterstock_1072042487_william_potter
William Potter / Shutterstock.com
25 July 2023FeaturesAmericasDavid Pardue, Patti Bartis and Sarah Hutchins

Navigating the rising wave against non-competes

Non-competes and other restrictive covenants faced a tidal wave of criticism this year, from the White House to state legislatures. The Federal Trade Commission (FTC) is not waiting to finalise or debate its proposed non-compete ban before stepping up enforcement against businesses.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Cigna pursues trade secrets in ‘non-competes’ dispute
31 January 2023   Move comes as Federal Trade Commission proposes controversial ban on non-compete clauses | Former executive requested list of “top clients” on day of resignation.
Americas
AltaThera hits competitor with trade secret suit
1 September 2022   Suit claims a contractor used AltaThera secrets to launch a rival heart arrhythmia drug | Chicago-based company wants the court to add its founder as co-inventor on patent.


Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024

More on this story

Big Pharma
Cigna pursues trade secrets in ‘non-competes’ dispute
31 January 2023   Move comes as Federal Trade Commission proposes controversial ban on non-compete clauses | Former executive requested list of “top clients” on day of resignation.
Americas
AltaThera hits competitor with trade secret suit
1 September 2022   Suit claims a contractor used AltaThera secrets to launch a rival heart arrhythmia drug | Chicago-based company wants the court to add its founder as co-inventor on patent.

More on this story

Big Pharma
Cigna pursues trade secrets in ‘non-competes’ dispute
31 January 2023   Move comes as Federal Trade Commission proposes controversial ban on non-compete clauses | Former executive requested list of “top clients” on day of resignation.
Americas
AltaThera hits competitor with trade secret suit
1 September 2022   Suit claims a contractor used AltaThera secrets to launch a rival heart arrhythmia drug | Chicago-based company wants the court to add its founder as co-inventor on patent.

More features

Bayer gains exclusive licence for heart drug in Japan
McGuireWoods expands team with ex-Novo Nordisk GC
Paul, Weiss swoops for senior duo from Weil, Gotshal
UPC bans Meril Life Sciences from selling infringing heart valve
SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic
Kathi Vidal to rejoin previous firm as partner following USPTO departure
‘We took Ravgen head-on’: How we won zero-damages and others didn't
Bristol Myers Squibb leader named INTA 2025 president